Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 May;14(5):624-7.
doi: 10.1128/CVI.00368-06. Epub 2007 Mar 14.

Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay

Affiliations
Clinical Trial

Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay

Magdia De Jesus et al. Clin Vaccine Immunol. 2007 May.

Abstract

Given the recent report of a false-positive result in the Platelia Aspergillus enzyme immunoassay in a patient with cryptococcosis and in yeast extracts and purified galactoxylomannan of Cryptococcus neoformans, we evaluated culture extracts, purified polysaccharides, clinical specimens, and specimens from animals following experimental infection. Our results revealed no cross-reactions.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Comparison of the structures of the major repeating units of GalM from Aspergillus spp. (13) and GalXM and GXM from C. neoformans (2). The lack of antigenic cross-reactivity between GalM and GalXM in the EIA is apparent in the comparison of these structures. In comparison to the β(1→5)-galactofuranose side chain epitope linked to an α(1→2)-mannotetraose core by an α(1→6) bond in GalM, GalXM differs by the absence of β(1→5)-galactofuranose side chains and the presence instead of β(1→3)-xylomannan side chains and an α(1→6)-galactopyranose core. The lack of structural similarity between the GalM and GXM further reflects the lack of cross-reactivity of the two antigens in the anti-GalM EIA. Green, galactofuranose or galactopyranose; blue, mannopyranose; red, xylose; gray, glucuronic acid. The asterisk near the 1→3 galactofuranosylmannopyranose bond indicates that there is currently uncertainty as to whether this linakge is α or β in configuration.

Similar articles

Cited by

References

    1. Beenhouwer, D. O., S. Shapiro, M. Feldmesser, A. Casadevall, and M. D. Scharff. 2001. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect. Immun. 69:6445-6455. - PMC - PubMed
    1. Bose, I., A. J. Reese, J. J. Ory, G. Janbon, and T. L. Doering. 2003. A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot. Cell 2:655-663. - PMC - PubMed
    1. Chaka, W., A. F. Verheul, V. V. Vaishnav, R. Cherniak, J. Scharringa, J. Verhoef, H. Snippe, and A. I. Hoepelman. 1997. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J. Immunol. 159:2979-2985. - PubMed
    1. Dalle, F., P. E. Charles, K. Blanc, D. Caillot, P. Chavanet, F. Dromer, and A. Bonnin. 2005. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J. Clin. Microbiol. 43:2929-2931. - PMC - PubMed
    1. James, P. G., and R. Cherniak. 1992. Galactoxylomannans of Cryptococcus neoformans. Infect. Immun. 60:1084-1088. - PMC - PubMed

Publication types